Eight Weeks of Esomeprazole Therapy Reduces Symptom Relapse, Compared With 4 Weeks, in Patients With Los Angeles Grade A or B Erosive Esophagitis
Keywords: Esophagus; GERD; Comparative Trial; Acid Reflux; CSR; complete symptom resolution; GERD; gastroesophageal reflux disease; GERDQ; gastroesophageal reflux disease questionnaire; ITT; intention to treat; PP; per protocol; PPI; proton pump inhibitor;